Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience

Tarih
2015
Yazar
Basaran, Mert
Tuncer, Samuray
Dogan, Oner
Buyukbabani, Nesimi
Tanyildiz, Burak
Üst veri
Tüm öğe kaydını göster
Özet
Purpose: To evaluate the efficacy of systemic rituximab immunotherapy in the management of primary ocular adnexal lymphomas (OAL).
Bağlantı
http://hdl.handle.net/20.500.12627/94855
https://doi.org/10.3109/02713683.2014.959605
Koleksiyonlar